Cargando…
MSC Based Therapies—New Perspectives for the Injured Lung
Chronic lung diseases pose a tremendous global burden. At least one in four people suffer from severe pulmonary sequelae over the course of a lifetime. Despite substantial improvements in therapeutic interventions, persistent alleviation of clinical symptoms cannot be offered to most patients affect...
Autores principales: | Behnke, Judith, Kremer, Sarah, Shahzad, Tayyab, Chao, Cho-Ming, Böttcher-Friebertshäuser, Eva, Morty, Rory E., Bellusci, Saverio, Ehrhardt, Harald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141210/ https://www.ncbi.nlm.nih.gov/pubmed/32138309 http://dx.doi.org/10.3390/jcm9030682 |
Ejemplares similares
-
MSC Based Therapies to Prevent or Treat BPD—A Narrative Review on Advances and Ongoing Challenges
por: Goetz, Maurizio J., et al.
Publicado: (2021) -
TRAIL protects the immature lung from hyperoxic injury
por: Shahzad, Tayyab, et al.
Publicado: (2022) -
The Potentials and Caveats of Mesenchymal Stromal Cell-Based Therapies in the Preterm Infant
por: Gronbach, Judith, et al.
Publicado: (2018) -
Oxygen Toxicity to the Immature Lung—Part I: Pathomechanistic Understanding and Preclinical Perspectives
por: Choi, Yesi, et al.
Publicado: (2021) -
Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development
por: Shahzad, Tayyab, et al.
Publicado: (2016)